How can I (or my colleague) apply?

Please contact the chairs of CVCT

• Pr Faiez Zannad

• Dr Bertram Pitt

What Can the Fellowship Offer?

• Work with Executive/Steering Committees and clinician scientists in Boehringer Ingelheim on CV outcome trial(s).

• Undertake analyses of datasets that complements the fellow’s interest.

APPLICATION DEADLINE: January 31, 2021

ADVANCED FELLOWSHIP IN CV TRIALS

What problem are we trying to solve?

• Without a steady supply of talent, innovation in outcome-based cardiovascular drug/device development is at risk.

• Currently, there are only limited opportunities, if any, for clinical academics to gain expertise in the conduct of these global trials.

Why Boehringer Ingelheim?

• Boehringer Ingelheim has a strong legacy of cardiovascular outcome trials, including EMPA-REG OUTCOME and Emperor-Reduced trials.

• As a family-owned company, Boehringer Ingelheim plans in generations.

• This partnership with CVCT is a unique opportunity to nurture future leaders in cardiovascular medicine.